5 years ago
Skin Analytics Secures £4M to Combat Skin Cancer with AI-Powered Screening
Skin Analytics, a UK-based startup, has raised £4 million in Series A funding to expand its AI-powered skin cancer screening service
The company's technology has been clinically validated and is able to identify skin cancers, pre-cancerous lesions, and benign lesions with the same accuracy as a dermatologist
Skin Analytics plans to use the funding to expand its focus to the US market after receiving Breakthrough Device Designation from the FDA.
ProblemHealthcare
"Eradicating skin cancer as it's the world's most common cancer with increasing incidence globally, while also addressing the global shortage of dermatologists"
Solution
"Skin Analytics developed a CE marked medical device that uses AI to identify skin cancers, pre-cancerous and benign lesions to the same level as a dermatologist, enabling health systems and insurers to increase dermatology capacity by reducing the burden of diagnosis for dermatologists"